SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Nov 2, 2024 | (Q2)Aug 3, 2024 | (Q1)May 4, 2024 | (FY)Feb 3, 2024 | (Q4)Feb 3, 2024 | (Q3)Oct 28, 2023 | (Q2)Jul 29, 2023 | (Q1)Apr 29, 2023 | (FY)Jan 28, 2023 | (Q4)Jan 28, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -47.79%-167M | -95.18%8M | 22.86%129M | -19.20%1.31B | 1.77%1.15B | -161.08%-113M | 201.82%166M | -57.66%105M | -40.45%1.62B | -39.76%1.13B |
Net income from continuing operations | -30.00%28M | 781.82%150M | -60.00%62M | -91.08%105M | -113.36%-68M | -62.62%40M | -108.00%-22M | -45.80%155M | -17.69%1.18B | -31.49%509M |
Operating gains losses | -1,550.00%-66M | ---- | ---- | 20.83%-57M | -215.38%-41M | 85.19%-4M | -160.00%-3M | 75.68%-9M | -26.32%-72M | 43.48%-13M |
Depreciation and amortization | -1.72%228M | -0.93%213M | -0.92%216M | 4.67%897M | 5.94%232M | 3.11%232M | 3.86%215M | 5.83%218M | -1.95%857M | 6.31%219M |
Deferred tax | -533.33%-13M | -78.57%-25M | 68.75%-10M | -542.11%-244M | -728.13%-201M | 109.38%3M | 33.33%-14M | -88.24%-32M | -300.00%-38M | --32M |
Other non cash items | -60.00%4M | -98.39%2M | 0.00%3M | 188.00%144M | -30.00%7M | -71.43%10M | 4,033.33%124M | 50.00%3M | -69.88%50M | 0.00%10M |
Change In working capital | 20.28%-338M | -101.95%-311M | 29.27%-174M | -35.24%-614M | -38.95%210M | -178.95%-424M | 64.43%-154M | -15.49%-246M | -332.82%-454M | -61.90%344M |
-Change in receivables | 760.00%43M | -131.25%-10M | -22.22%35M | 333.33%7M | 21.88%-75M | -66.67%5M | 146.15%32M | -30.77%45M | 85.71%-3M | -12.94%-96M |
-Change in inventory | 0.84%-1.88B | -34.73%312M | 19.71%-273M | -185.34%-99M | -22.34%1.66B | -5.75%-1.9B | 38.15%478M | 40.66%-340M | 119.02%116M | 21.51%2.14B |
-Change in prepaid assets | -145.00%-9M | 277.27%39M | -253.13%-49M | 127.27%18M | -20.00%-12M | 171.43%20M | -46.67%-22M | 346.15%32M | -69.23%-66M | -300.00%-10M |
-Change in payables and accrued expense | 5.22%1.45B | -6.84%-547M | 256.10%146M | -51.82%-460M | 16.53%-1.37B | -18.45%1.38B | 10.18%-512M | -80.93%41M | -165.44%-303M | -19.81%-1.64B |
-Change in other working capital | -16.42%56M | 19.23%-105M | -37.50%-33M | 59.60%-80M | 115.22%7M | 276.32%67M | 37.20%-130M | -125.81%-24M | -149.25%-198M | -107.74%-46M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -47.79%-167M | -95.18%8M | 22.86%129M | -19.20%1.31B | 1.77%1.15B | -161.08%-113M | 201.82%166M | -57.66%105M | -40.45%1.62B | -39.76%1.13B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 55.68%-82M | 40.23%-156M | 19.63%-217M | 21.90%-913M | 34.33%-197M | 47.74%-185M | 18.69%-261M | -39.18%-270M | -215.95%-1.17B | -79.64%-300M |
Capital expenditure reported | 1.11%-89M | 7.53%-86M | 7.41%-75M | 11.06%-362M | -24.05%-98M | ---90M | ---93M | 10.00%-81M | -67.49%-407M | ---79M |
Net PPE purchase and sale | 108.79%8M | 58.33%-70M | 21.05%-150M | 27.43%-545M | 55.96%-96M | 60.09%-91M | 18.84%-168M | -93.88%-190M | -295.26%-751M | -179.49%-218M |
Net other investing changes | 75.00%-1M | --0 | 700.00%8M | 45.45%-6M | 0.00%-3M | -100.00%-4M | --0 | 116.67%1M | -117.46%-11M | -200.00%-3M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 55.68%-82M | 40.23%-156M | 19.63%-217M | 21.90%-913M | 34.33%-197M | 47.74%-185M | 18.69%-261M | -39.18%-270M | -215.95%-1.17B | -79.64%-300M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -136.61%-82M | -17.14%-82M | 25.53%-70M | 83.02%-220M | 3.78%-280M | 14.87%224M | 33.96%-70M | 91.41%-94M | 45.57%-1.3B | 6.13%-291M |
Net issuance payments of debt | -185.53%-136M | --0 | 0.00%-1M | 99.31%-2M | 13.04%-160M | -13.11%159M | --0 | 99.65%-1M | 81.97%-291M | -30.50%-184M |
Net common stock issuance | --0 | --0 | --0 | 93.68%-38M | --0 | --0 | 82.35%-3M | 94.01%-35M | -21.91%-601M | --0 |
Cash dividends paid | -6.67%-48M | -6.67%-48M | -6.67%-48M | -4.62%-181M | -6.98%-46M | -4.65%-45M | -7.14%-45M | 0.00%-45M | -92.22%-173M | 2.27%-43M |
Net other financing activities | -7.27%102M | -54.55%-34M | -61.54%-21M | 100.43%1M | -15.63%-74M | 100.00%110M | 52.17%-22M | 92.61%-13M | -25.54%-231M | -186.49%-64M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -136.61%-82M | -17.14%-82M | 25.53%-70M | 83.02%-220M | 3.78%-280M | 14.87%224M | 33.96%-70M | 91.41%-94M | 45.57%-1.3B | 6.13%-291M |
Net cash flow | ||||||||||
Beginning cash position | 47.17%649M | 45.05%879M | 19.88%1.04B | -49.56%865M | 11.55%367M | 45.54%441M | -10.22%606M | -49.56%865M | -2.22%1.72B | 2.49%329M |
Current changes in cash | -347.30%-331M | -39.39%-230M | 39.00%-158M | 120.24%172M | 25.00%670M | -384.62%-74M | 55.65%-165M | 75.10%-259M | -2,079.49%-850M | -61.55%536M |
End cash Position | -13.35%318M | 47.17%649M | 45.05%879M | 19.88%1.04B | 19.88%1.04B | 11.55%367M | 45.54%441M | -10.22%606M | -49.56%865M | -49.56%865M |
Free cash flow | -28.86%-384M | -91.18%-195M | 47.64%-100M | -2.50%312M | 10.80%903M | -37.96%-298M | 61.65%-102M | -1,369.23%-191M | -84.87%320M | -50.87%815M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |